Lv1
12 积分 2024-04-25 加入
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
22小时前
待确认
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
3天前
已完结
Personalized vaccines for cancer immunotherapy
3天前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
6天前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
6天前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
6天前
已完结
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
7天前
已完结
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
7天前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
12天前
已完结
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
25天前
已完结
皖公网安备34019202002308
